Latest News


New Roche publication – Absorption, distribution, metabolism and excretion (ADME) of the ALK inhibitor alectinib: results from an absolute bioavailability and mass balance study in healthy subjects

June 9, 2016

Retrieve the publication from here

 

AstraZeneca – Incorporation of an IV [14C]-microtracer dose into a first in human study to determine the absolute oral bioavailability of AZD5122

May 18, 2016

Retrieve the paper from here

 

Taiho prodrug TAS-102 – PK, excretory pathways and metabolism determined in patients with advanced solid tumors using HPLC plus AMS

March 24, 2016

Get the paper from Cancer Chemotherapy and Pharmacology here

TAS-102 was approved in America in 2015 as Lonsurf®.

 

 

A guide to transferring and validating quantitative analytical methods for LC+AMS

October 28, 2015

This white paper describes why LC or LC-MS/MS methods must be carefully evaluated as they are adopted for LC+AMS use and why the resultant LC+AMS method must be fully validated before use.  A three-batch validation is the only way to ensure method reproducibility and deliver LC+AMS data reliably.

Download here

 

Xceleron latest presentation – The successful application of carbon isotopes in preclinical and clinical pharmaceutical research

October 6, 2015

Presented at the 21st Workshop on the Synthesis and Applications of Isotopes and Isotopically Labelled Compounds, International Isotope Society-Central European Division, Bad Soden, Germany

Download the presentation from here

 

Xceleron Webinar – Genentech and GSK discuss microtracer use

September 16, 2015

Successful Clinical [14C] Microtracer Investigations – Case Studies from GSK and Genentech

Thursday, 24th September 2015 at 11:00 am EDT – 12:00 pm EDT

Go here to pre-register for the webinar

 

Xceleron giving Plenary Lecture at 21st Annual IIS-CED Workshop, Bad Soden Germany, 2nd October

August 17, 2015

Stephen English – “The successful application of carbon isotopes in preclinical and clinical pharmaceutical research”

Friday, 2nd October 2015

International Isotope Society-Central European Division

21st Workshop on the Synthesis and Applications of Isotopes and Isotopically Labelled Compounds

Bad Soden, Germany

 

 

Xceleron latest presentation

June 11, 2015

Surveying the Boundaries of Accelerator Mass Spectrometry: The Widening Scope of an Evolving Technology

Read the presentation

 

New Xceleron presentation 9th June

June 1, 2015

Stephen English Surveying the boundaries of accelerator mass spectrometry: the widening scope of an evolving technology
12th International Symposium on the Synthesis and Applications of Isotopes and Isotopically Labelled Compounds, Princeton NJ
June 9th
16:20 – 16:40
Session 6
McDonnell AO1

 

New webinar materials are now available to view

April 22, 2015

Go here to download speaker presentations, listen to and watch a recording of the presentations or read our comprehensive Q&A

 

  • Latest News

    New Roche publication – Absorption, distribution, metabolism and excretion (ADME) of the ALK inhibitor alectinib: results from an absolute bioavailability and mass balance study in healthy subjects

    Read more »

  • What our clients are saying about us...

    "...AMS [is] an invaluable tool in our early drug development program, allowing us to quickly assess bioavailability in humans and focus resources on our most promising drug candidates going forward."

    See more client quotes »

  • Get Phase II Ready

    Find out how we can help you accelerate your drug-development program.

    Email us now »

© Xceleron 2016 All Rights Reserved.